GORE ENFORM Preperitoneal Biomaterial
Device Devices
PDI 00733132644568
General payments
$2,159,259
Research payments
$42,156
Through program year 2025, $2,159,259 in general payments and $42,156 in research payments were reported against GORE ENFORM Preperitoneal Biomaterial (Devices).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $387,871 | 1,119 |
| 2025 | Research | $2,808 | 1 |
| 2024 | General | $457,473 | 1,306 |
| 2023 | General | $748,763 | 1,069 |
| 2023 | Research | $39,348 | 4 |
| 2022 | General | $525,560 | 824 |
| 2021 | General | $39,593 | 316 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,634 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.